ArticleCancer medicine2022

Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.

Natalia V Mitiushkina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.